Reports and Publications

The World Health Organization (WHO) developed the Global Influenza Strategy for 2019–2030 to enhance global and national pandemic preparedness, to combat the ongoing threat of zoonotic influenza, and to improve seasonal influenza prevention and control in all countries.

The purpose of this guidance document is to provide feed and ingredient manufacturers with recommendations that may be used to develop a biosecurity plan to control the potential spread of animal diseases through feed and feed ingredients.

This report provides recommendations issued by the US Centers for Disease Control and Prevention (CDC) for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals.

This toolkit helps you work with key stakeholders to develop methods for the dispensing of medical countermeasures (such as antibiotics, antivirals, vaccines, and supplies) during public health emergencies involving public health agencies, hospitals, long term care facilities, and pharmacies.

Per a directive from the US Centers for Disease Control and Prevention (CDC) large metropolitan regions have been tasked with delivering medication to the public within 48 hours after notification of a biological emergency event.

This document presents a set of recommended standards for mass antibiotic dispensing that focus on the “points of dispensing” (or PODs, locations where the members of the public would go to receive life-saving antibiotics or other medical countermeasures during a large-scale public health emergen

This paper summarizes clinical syndromes and possible treatment options, for both developed and low-resource settings, and offer performance indicators and clinical metrics for case management.

This paper offers an analytical framework is used to assess the risks and benefits of such dual use research, and relevant components of biosecurity policy and the biodefense enterprise (including the acquisition of medical countermeasures) in the United States are discussed.

This document outlines key topics, relevant resources, and current promising practices state and local medical countermeasure (MCM) planners should consider when creating and implementing plans to transition emergency mass dispensing operations from the initial 10-day antibiotic distribution and

Presents a review of best practices, collates available evidence and identifies areas that require further investigation.